Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

MiR-340 Expression As a Prognostic Marker to Guide Clinical Decision-Making in Acute Myeloid Leukemia

Tingting Shao, Yuan Feng, Ninghan Zhang, Rong Wang, Ting Pan, Jianlin Qiao, PhD, Mingshan Niu, PhD, Kailin Xu, MD

Blood (2019) 134 (Supplement_1): 2728.

https://doi.org/10.1182/blood-2019-126522

Published: 2019

Journal Articles

Detection of Actionable BCR-ABL1 Kinase Domain (KD) Mutations in Chronic Myeloid Leukemia (CML) Patients with Failure and Warning Response to Tyrosine Kinase Inhibitors (TKIs): Potential Impact of Next-Generation Sequencing (NGS) and Droplet Digital PCR (ddPCR) on Clinical Decision Making

Blood (2019) 134 (Supplement_1): 661.

https://doi.org/10.1182/blood-2019-126767

Published: 2019

Journal Articles

An IDO1 -Related 3-Gene Signature Predicts Overall Survival in Intermediate-Risk Acute Myeloid Leukemia

Simone Ragaini, MD, Sarah Wagner, BSc MSc, Giovanni Marconi, Sarah Parisi, MD PhD, Chiara Sartor, MD, Jacopo Nanni, MD, Gianluca Cristiano, Annalisa Talami, MD, Matteo Olivi, MD, Darina Ocadlikova, PhD, Marilena Ciciarello, PhD, Giulia Corradi, PhD, Emanuela Ottaviani, Cristina Papayannidis, Stefania Paolini, MD PhD, Jayakumar Vadakekolathu, PhD, Michele Cavo, Sergio Rutella, MD PhD FRCPath, Antonio Curti, MD PhD

Blood (2019) 134 (Supplement_1): 5193.

https://doi.org/10.1182/blood-2019-128348

Published: 2019

Journal Articles

Refining Blood Products Utilization: Every One (unit) Matters

Khaled Deeb, PhD MBA, MD, Chen Zhang, MD, Stanislav Ivanov, MD MPH, Eric Szu, MD, Louis Lit, MD

Blood (2019) 134 (Supplement_1): 4985.

https://doi.org/10.1182/blood-2019-121339

Published: 2019

Journal Articles

Trends in ADAMTS13 Activity Testing over the Last 7 Years in a Single UK TTP Specialist Centre

Kat Moss, MBBS, MRCP, Colin Downey, Ashley Lawrenson, Tina Dutt, PhD MBBS, BSc, FRCPath, FRCP, Rebecca J Shaw

Blood (2018) 132 (Supplement 1): 3526.

https://doi.org/10.1182/blood-2018-99-119331

Published: 2018

Journal Articles

Estimating the Effect of Individual Agents in the Treatment of Relapsed, Refractory Multiple Myeloma (RRMM)

Neil Hawkins, Karthik Ramasamy, Sujith Dhanasiri

Blood (2018) 132 (Supplement 1): 2013.

https://doi.org/10.1182/blood-2018-99-111804

Published: 2018

Journal Articles

Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia

Kah Poh Loh, MBBCHBAO, Sindhuja Kadambi, MD, Supriya G. Mohile, MD MS, Jason H. Mendler, MD PhD, Jane L. Liesveld, MD, Kristen M. O'Dwyer, MD, Michael W. Becker, MD, Colin M. McHugh, MD, Marsha Wittink, MD MBE, Wendy Stock, MD, Navneet S. Majhail, MD MS, Tanya Wildes, MD, Paul Duberstein, PhD, Heidi D. Klepin, MD MS

Blood (2018) 132 (Supplement 1): 2246.

https://doi.org/10.1182/blood-2018-99-114178

Published: 2018

Journal Articles

Dynamic BH3 Profiling Predicts Patient Response and MRD Status in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Frontline Treatment with Kinase Inhibitor Plus FCR (KI+FCR)

Timothy Z. Lehmberg, BA, Rebecca Valentin, MD, Stacey M. Fernandes, BS, Jennifer R. Brown, MD PhD, Matthew S Davids

Blood (2018) 132 (Supplement 1): 4395.

https://doi.org/10.1182/blood-2018-99-115151

Published: 2018

Journal Articles

How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations

Benjamin Djulbegovic, MD, Tea Reljic, MPH, Shira Elqayam, PhD, Adam Cuker, MD MS, Iztok Hozo, PhD, Qi Zhou, PhD, Shelly-Anne Li, PhDc), Paul Alexander, PhD, Nieuwlaat Robby, PhD, Wojtek Wiercioch, MD, Holger Schünemann, MD, Gordon Guyatt, MD

Blood (2018) 132 (Supplement 1): 4707.

https://doi.org/10.1182/blood-2018-99-110132

Published: 2018

Journal Articles

Applicability of the AML knowledge bank approach

Uma Borate

Blood (2018) 132 (8): 775–776.

https://doi.org/10.1182/blood-2018-06-857557

Published: 2018

Journal Articles

Teaching Hematology to Fellows: A Qualitative Study

Ethan Bernstein, MD, Nikolai A. Podoltsev, MD PhD, Alfred Lee, MD PhD

Blood (2017) 130 (Supplement 1): 5641.

https://doi.org/10.1182/blood.V130.Suppl_1.5641.5641

Published: 2017

Journal Articles

Predictive Simulation Modeling of Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Patient Genomics Identifies Targeted Combination Treatment Options

Leylah M. Drusbosky, PhD, Ansu Kumar, MS, Shwetha K, BE, Priyanka Bhargav, BE, Ashish Choudhary, MS, Soumyashree L, BE, Shivgonda C. Birajdar, MCA, Kunal Ghosh Roy, MS, Taher Abbasi, MS, MBA, Shireen Vali, PhD, Manju Sengar, MD DM, Girish Chinnaswamy, MD MRCP, Bijal D. Shah, MD, Christopher R. Cogle, MD

Blood (2017) 130 (Supplement 1): 2708.

https://doi.org/10.1182/blood.V130.Suppl_1.2708.2708

Published: 2017

Journal Articles

IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis

Emelie Curovic Curovic Rotbain, MD, Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, Klaus Rostgaard, MSc., Michael A Andersen, MD, Carsten Utoft Niemann, MD PhD, Henrik Frederiksen, associate professor, consultant, PhD

Blood (2017) 130 (Supplement 1): 1742.

https://doi.org/10.1182/blood.V130.Suppl_1.1742.1742

Published: 2017

Journal Articles

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Christian Scharenberg, MD, Petter S. Woll, PhD, Valentina Giai, MD PhD, Andrea Pellagatti, PhD, Leonie Saft, MD PhD, Marios Dimitriou, Martin Jädersten, Monika Jansson, Iyadh Douagi, PhD, Donna S. Neuberg, ScD, Mohsen Karimi, Katarina Le Blanc, MD, PhD, Jacqueline Boultwood, PhD, Sten Eirik Jacobsen, MD PhD, Eva Hellstrom-Lindberg, MD PhD

Blood (2016) 128 (22): 4329.

https://doi.org/10.1182/blood.V128.22.4329.4329

Published: 2016

Journal Articles

Characterization of Genomic Rearrangements Involving CIITA and SOCS1 U sing Targeted Capture Sequencing of Archival Tissue Specimens

Anja Mottok, Lauren Chong, MSc, Susana Ben-Neriah, Bruce Woolcock, MSc, Yongjun Zhao, PhD, Marco A Marra, PhD, David W. Scott, Randy D. Gascoyne, Andrew J. Mungall, Christian Steidl

Blood (2016) 128 (22): 2925.

https://doi.org/10.1182/blood.V128.22.2925.2925

Published: 2016

Journal Articles

the Use of Tailored Feedback to Improve Hematologist Competence and Clinical Decision Making for the Treatment of Patients with Multiple Myeloma: a Novel Web-Based Educational Solution

Patricia Repetto, M.Ed., CHCP, Noopur S. Raje, MD, Sara R Fagerlie, PhD CHCP

Blood (2016) 128 (22): 3570.

https://doi.org/10.1182/blood.V128.22.3570.3570

Published: 2016

Journal Articles

Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot

Pauline Robbe, Kate Ridout, Jennifer Becq, Miao He, Ruth Clifford, MD, Reem Alsolami, Adam Burns, Samantha JL Knight, Melanie Oates, Dena Howard, Andrew R. Pettitt, Augusto Rendon, Niko Popitsch, Peter Hillmen, Jenny C Taylor, Mark Caulfield, David Bentley, Clare Turnbull, Anna Schuh, MD PhD

Blood (2016) 128 (22): 2022.

https://doi.org/10.1182/blood.V128.22.2022.2022

Published: 2016

Journal Articles

Evaluating the Effects of an Evidence-Based Hemostasis and Thrombosis Treatment Algorithm Tool on Medical Practitioner and Trainee Clinical Decision Making

Joseph Shatzel, MD, Derrick Tao, Sven R Olson, MD, Edward Kim, Molly Daughety, MD, Thomas G. Deloughery, MD, Merav Sendowski, MD

Blood (2016) 128 (22): 4736.

https://doi.org/10.1182/blood.V128.22.4736.4736

Published: 2016

Journal Articles

Using Machine Intelligence Algorithms to Develop a Geno-Clinical Model to Predict Responses to Hypomethylating Agents in Myelodysplastic Syndromes

Aziz Nazha, MD, Mikkael A. Sekeres, MD MS, Rafael Bejar, MD PhD, John Barnard, PhD, Karam Al-Issa, MD, Bartlomiej P Przychodzen, MSc, Matt Kalaycio, MD, Michael J. Clemente, M.S., Cassandra M. Hirsch, BSc, Benjamin L Ebert, MD PhD, Jaroslaw P. Maciejewski

Blood (2016) 128 (22): 3193.

https://doi.org/10.1182/blood.V128.22.3193.3193

Published: 2016

Journal Articles

Impact of Non Professional Physicians' Characteristics on Medical Decision Making in Older Patients with Acute Myeloid Leukemia

Pierre Bories, MD, Sébastien Lamy, PhD, Celestine Simand, Sarah Bertoli, MD PhD, Sandra Malak, MD, Luc Mathieu Fornecker, MD PhD, Stephane Moreau, MD, Christian Recher, MD PhD, Antoine Nebout, PhD

Blood (2016) 128 (22): 3576.

https://doi.org/10.1182/blood.V128.22.3576.3576

Published: 2016

NARROW

MiR-340 Expression As a Prognostic Marker to Guide Clinical Decision-Making in Acute Myeloid Leukemia

Detection of Actionable BCR-ABL1 Kinase Domain (KD) Mutations in Chronic Myeloid Leukemia (CML) Patients with Failure and Warning Response to Tyrosine Kinase Inhibitors (TKIs): Potential Impact of Next-Generation Sequencing (NGS) and Droplet Digital PCR (ddPCR) on Clinical Decision Making

An IDO1 -Related 3-Gene Signature Predicts Overall Survival in Intermediate-Risk Acute Myeloid Leukemia

Refining Blood Products Utilization: Every One (unit) Matters

Trends in ADAMTS13 Activity Testing over the Last 7 Years in a Single UK TTP Specialist Centre

Estimating the Effect of Individual Agents in the Treatment of Relapsed, Refractory Multiple Myeloma (RRMM)

Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia

Dynamic BH3 Profiling Predicts Patient Response and MRD Status in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Frontline Treatment with Kinase Inhibitor Plus FCR (KI+FCR)

How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations

Applicability of the AML knowledge bank approach

Teaching Hematology to Fellows: A Qualitative Study

Predictive Simulation Modeling of Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Patient Genomics Identifies Targeted Combination Treatment Options

IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Characterization of Genomic Rearrangements Involving CIITA and SOCS1 U sing Targeted Capture Sequencing of Archival Tissue Specimens

the Use of Tailored Feedback to Improve Hematologist Competence and Clinical Decision Making for the Treatment of Patients with Multiple Myeloma: a Novel Web-Based Educational Solution

Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot

Evaluating the Effects of an Evidence-Based Hemostasis and Thrombosis Treatment Algorithm Tool on Medical Practitioner and Trainee Clinical Decision Making

Using Machine Intelligence Algorithms to Develop a Geno-Clinical Model to Predict Responses to Hypomethylating Agents in Myelodysplastic Syndromes

Impact of Non Professional Physicians' Characteristics on Medical Decision Making in Older Patients with Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only